TP53 and colorectal cancer: found that knocking down USP39 expression in a cisplatin-treated cell line indirectly enhances the cisplatin-induced apoptosis of colorectal cancer cells by increasing the stability of the p53 protein (54), suggesting that USP39 may play a role in the epigenetic regulation of cisplatin resistance.